Sands Capital Life Sciences Pulse Fund II L.P. 13D and 13G filings for Acrivon Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-11-25 4:25 pm Purchase | 2022-11-15 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Sands Capital Life Sciences Pulse Fund II L.P. | 1,652,606 7.900% | 1,652,606 (New Position) | Filing |